Globally, medicine regulatory authorities, research groups, international organisations, law enforcement agencies and other key stakeholders, including the pharmaceutical industry, are trying to keep patients safe and ensure that the benefits of modern medicine are delivered to patients. However, organisations working in this field tend to be fragmented with the wide diversity of professionals required to tackle this important issue, from chemists to lawyers, rarely discussing solutions together.
There has never been an opportunity for the diverse stakeholders involved in medicine quality and drug regulation to come together – within the framework of a specific academic conference – to share ideas and expertise, and to outline the coordinated steps that need to be taken to tackle the problem on an international scale.
Together with our partners, we organised the first-ever dedicated international conference on Medicine Quality and Public Health, which was held at Keble College, the University of Oxford, UK, from 23 to 28 September 2018.
The Conference provided a unique opportunity for health authorities, scientists, pharmacists, lawyers, national regulatory authorities, international organisations and others who are interested in this field to discuss the problem and outline the necessary steps to tackle falsified and substandard medical products on a global scale.